血流导向装置治疗未破裂颅内动脉瘤的围手术期并发症分析
本研究回顾性分析174例未破裂颅内动脉瘤患者使用血流导向装置治疗的围手术期不良事件和并发症,发现29例(16.7%)发生不良事件,10例(5.7%)发生并发症,5例(2.9%)出现神经功能缺损;完成1年随访的129例患者(179个动脉瘤)成功闭塞率为77.7%。
要点
- 血流导向装置治疗未破裂颅内动脉瘤围手术期不良事件发生率为16.7%。
- 围手术期并发症发生率为5.7%,神经功能缺损发生率为2.9%。
- 术后1年随访成功闭塞率为77.7%。
核心结论
- 血流导向装置治疗颅内动脉瘤效果满意,但围手术期不良事件发生率较高,需神经介入医师谨慎处理。
研究设计与样本
- 回顾性病例系列研究,纳入2020年1月至2024年1月解放军总医院第一医学中心神经介入科使用血流导向装置治疗的174例颅内未破裂动脉瘤患者,男63例、女111例,年龄(53.9±11.4)岁(范围:23~76岁)。
主要发现
- 174例患者(294个动脉瘤)共植入187枚血流导向装置(7种品牌),单纯支架栓塞151例次,联合弹簧圈辅助栓塞26例次,同时使用2枚装置5例次。
- 29例(16.7%,29/174)发生围手术期不良事件,包括支架打开不良10例、支架陷入瘤腔3例、导丝异常走位1例、穿支动脉闭塞4例、支架内血栓形成5例、脑出血3例、脑缺血3例。
- 10例(5.7%,10/174)发生并发症,其中5例(2.9%,5/174)术后发生神经功能缺损。
- 129例患者(179个动脉瘤)完成术后1年随访,OKM分级D级117个、C级22个,成功闭塞率为77.7%(139/179)。
关键数值与推荐
- 采用O'Kelly-Marotta(OKM)分级系统评估动脉瘤栓塞程度,以OKM分级C级或D级为成功闭塞。
临床怎么用
- 血流导向装置治疗未破裂颅内动脉瘤时需警惕围手术期不良事件,尤其是支架打开不良、支架内血栓形成等,应加强术中及术后监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the perioperative adverse events and complications of flow-diverter devices in the treatment of unruptured intracranial aneurysms. Methods: This is a retrospective case series study. The clinical and imaging data of 174 patients with unruptured intracranial aneurysms treated with flow-diverter devices in the Department of Neurointervention, Department of Neurology, the First Medical Center of Chinese People's Liberation Army General Hospital from January 2020 to January 2024 were retrospectively analyzed. There were 63 males and 111 females, with an age of (53.9±11.4) years (range:23 to 76 years).The occurrence, development and outcome of perioperative complications and related adverse events during treatment were collected and analyzed. The degree of aneurysm embolization was evaluated using the O'Kelly-Marotta (OKM) grading system,with OKM grade C and D as successful occlusion. Results: A total of 187 flow-diverter devices (from 7 different brands) were implanted in 174 patients (with 294 aneurysms). Of these, 151 cases involved standalone stent embolization, 26 cases involved stent embolization combined with coil assistance, and 5 cases involved the use of two flow-diverter devices simultaneously. Twenty-nine cases (16.7%,29/174) suffered intraoperative adverse events, including 10 cases of poor stents deployment, 3 cases of stents migration into the aneurysm sac, 1 cases of abnormal guidewire movement, 4 cases of ischemic events. Complications occurred in 10 patients (5.7%, 10/174), and neurological deficits occurred in 5 patients (2.9%, 5/174). A total of 129 patients completed follow-up for more than 12 months after surgery. There were 117 aneurysms with OKM grade D and 22 with OKM grade C, showing a satisfactory healing rate of 77.7% (139/179). Conclusion: The effect of flow-diverter devices in the treatment of intracranial aneurysms is satisfactory, but complications and adverse events cannot be ignored, especially the relatively high incidence of perioperative adverse events, which requires neurointerventional physicians to be vigilant. 目的: 探讨血流导向装置治疗颅内未破裂动脉瘤的围手术期不良事件和并发症发生情况。 方法: 本研究为回顾性病例系列研究。回顾性分析2020年1月至2024年1月解放军总医院第一医学中心神经内科医学部神经介入科使用血流导向装置治疗的174例颅内未破裂动脉瘤患者的临床和影像学资料。男性63例,女性111例,年龄(53.9±11.4)岁(范围:23~76岁)。收集并分析患者围手术期不良事件和并发症的发生、发展及转归情况。采用O′Kelly-Marotta(OKM)分级系统评估动脉瘤栓塞程度,以OKM分级C级或D级为成功闭塞。 结果: 174例患者(294个动脉瘤)共植入血流导向装置187枚(7种品牌),行单纯支架栓塞151例次,联合弹簧圈辅助栓塞26例次,同时使用2枚血流导向装置5例次。29例(16.7%,29/174)患者发生围手术期不良事件,包括支架打开不良10例、支架陷入瘤腔3例、导丝异常走位1例、穿支动脉闭塞4例、支架内血栓形成5例、脑出血3例、脑缺血3例。10例(5.7%,10/174)患者发生并发症,其中5例(2.9%,5/174)患者术后发生神经功能缺损。共129例患者(179个动脉瘤)完成术后1年随访,OKM分级D级的动脉瘤117个,C级22个,成功闭塞率为77.7%(139/179)。 结论: 血流导向装置治疗颅内动脉瘤效果满意,但围手术期不良事件发生率较高,需要神经介入医师谨慎处理。.
引用
- Wang XH, Zhang RJ, Tian N, et al. [Analysis of perioperative complications of flow-diverter devices in the treatment of unruptured intracranial aneurysms]. Zhonghua Wai Ke Za Zhi. 2024. PMID: 39606993. doi:10.3760/cma.j.cn112139-20240522-00253
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。